Chemokine CCL17 is expressed by dendritic cells in the CNS during experimental autoimmune encephalomyelitis and promotes pathogenesis of disease

Brain, Behavior, and Immunity

Volumn 66, Issue , 2017, Pages 382-393

  Ruland, Christina ^a   Renken, Hannes ^a   Kuzmanov, Ivan ^a   Fattahi Mehr, Arezoo ^a   Schwarte, Kathrin ^a   Cerina, Manuela ^a   Herrmann, Alexander ^a   Otte, David Marian ^b   Zimmer, Andreas ^b   Schwab, Nicholas ^a   Meuth, Sven G ^a   Arolt, Volker ^a   Klotz, Luisa ^a   Förster, Irmgard ^b   Scheu, Stefanie ^c   Alferink, Judith ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Blood brain barrier; CCL17; CCR4; Chemokines; CNS autoimmunity; DC; EAE; TH17; Tregs

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 23; THYMUS AND ACTIVATION REGULATED CHEMOKINE; CCL17 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CD4+ T LYMPHOCYTE; CELL EXPANSION; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DISEASE SEVERITY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; IMMUNOREGULATION; IN VITRO STUDY; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; TH17 CELL; ANIMAL; C57BL MOUSE; CELL MOTION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PATHOPHYSIOLOGY; SECRETION (PROCESS); SPLEEN;

ANIMALS; BLOOD-BRAIN BARRIER; CELL MOVEMENT; CHEMOKINE CCL17; DENDRITIC CELLS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; INTERLEUKIN-23; MICE, INBRED C57BL; MICE, KNOCKOUT; SPLEEN; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 85021438019     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2017.06.010     Document Type: Article

References (46)

1. Alferink, J., Lieberam, I., Reindl, W., Behrens, A., Weiss, S., Huser, N., Gerauer, K., Ross, R., Reske-Kunz, A.B., Ahmad-Nejad, P., Wagner, H., Forster, I., Compartmentalized production of CCL17 in vivo: strong inducibility in peripheral dendritic cells contrasts selective absence from the spleen. J. Exp. Med. 197:5 (2003), 585–599.
2. Alferink, J., Poppensieker, K., Otte, D.M., Klotz, L., Scheu, S., Maier, W., Zimmer, A., Reply to Othy et al.: dendritic cell-specific expression of CCR4 is required for development of EAE. Proc. Natl. Acad. Sci. 109:37 (2012), E2414–E2415.
3. Berahovich, R.D., Lai, N.L., Wei, Z., Lanier, L.L., Schall, T.J., Evidence for NK cell subsets based on chemokine receptor expression. J. Immunol. (Baltimore, Md.: 1950) 177:11 (2006), 7833–7840.
4. Bielecki, B., Jatczak-Pawlik, I., Wolinski, P., Bednarek, A., Glabinski, A., Central nervous system and peripheral expression of CCL19, CCL21 and their receptor CCR7 in experimental model of multiple sclerosis. Arch. Immunol. Ther. Exp. 63:5 (2015), 367–376.
5. Bittner, S., Ruck, T., Schuhmann, M.K., Herrmann, A.M., Moha ou Maati, H., Bobak, N., Gobel, K., Langhauser, F., Stegner, D., Ehling, P., Borsotto, M., Pape, H.C., Nieswandt, B., Kleinschnitz, C., Heurteaux, C., Galla, H.J., Budde, T., Wiendl, H., Meuth, S.G., Endothelial TWIK-related potassium channel-1 (TREK1) regulates immune-cell trafficking into the CNS. Nat. Med. 19:9 (2013), 1161–1165.
6. Christophi, G.P., Christophi, J.A., Gruber, R.C., Mihai, C., Mejico, L.J., Massa, P.T., Jubelt, B., Quantitative differences in the immunomodulatory effects of Rebif and Avonex in IFN-beta 1a treated multiple sclerosis patients. J. Neurol. Sci. 307:1–2 (2011), 41–45.
7. Cua, D.J., Sherlock, J., Chen, Y., Murphy, C.A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., Zurawski, S., Wiekowski, M., Lira, S.A., Gorman, D., Kastelein, R.A., Sedgwick, J.D., Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421:6924 (2003), 744–748.
8. Deli, M.A., Abraham, C.S., Niwa, M., Falus, A., N, N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine increases the permeability of primary mouse cerebral endothelial cell monolayers. Inflamm. Res. 52:Suppl 1 (2003), S39–S40.
9. Dogan, R.N., Long, N., Forde, E., Dennis, K., Kohm, A.P., Miller, S.D., Karpus, W.J., CCL22 regulates experimental autoimmune encephalomyelitis by controlling inflammatory macrophage accumulation and effector function. J. Leukoc. Biol. 89:1 (2011), 93–104.
10. Flugel, A., Berkowicz, T., Ritter, T., Labeur, M., Jenne, D.E., Li, Z., Ellwart, J.W., Willem, M., Lassmann, H., Wekerle, H., Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity 14:5 (2001), 547–560.
11. Franciotta, D., Zardini, E., Ravaglia, S., Piccolo, G., Andreoni, L., Bergamaschi, R., Romani, A., Tavazzi, E., Naldi, P., Ceroni, M., Marchioni, E., Cytokines and chemokines in cerebrospinal fluid and serum of adult patients with acute disseminated encephalomyelitis. J. Neurol. Sci. 247:2 (2006), 202–207.
12. Galimberti, D., Scalabrini, D., Fenoglio, C., De Riz, M., Comi, C., Venturelli, E., Cortini, F., Piola, M., Leone, M., Dianzani, U., D'Alfonso, S., Monaco, F., Bresolin, N., Scarpini, E., Gender-specific influence of the chromosome 16 chemokine gene cluster on the susceptibility to Multiple Sclerosis. J. Neurol. Sci. 267:1–2 (2008), 86–90.
13. Gartner, D., Hoff, H., Gimsa, U., Burmester, G.R., Brunner-Weinzierl, M.C., CD25 regulatory T cells determine secondary but not primary remission in EAE: impact on long-term disease progression. J. Neuroimmunol. 172:1–2 (2006), 73–84.
14. Globisch, T., Steiner, N., Fulle, L., Lukacs-Kornek, V., Degrandi, D., Dresing, P., Alferink, J., Lang, R., Pfeffer, K., Beyer, M., Weighardt, H., Kurts, C., Ulas, T., Schultze, J.L., Forster, I., Cytokine-dependent regulation of dendritic cell differentiation in the splenic microenvironment. Eur. J. Immunol. 44:2 (2014), 500–510.
15. Greter, M., Heppner, F.L., Lemos, M.P., Odermatt, B.M., Goebels, N., Laufer, T., Noelle, R.J., Becher, B., Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat. Med. 11:3 (2005), 328–334.
16. Gu, W., Zhang, F., Xue, Q., Ma, Z., Lu, P., Yu, B., Transplantation of bone marrow mesenchymal stem cells reduces lesion volume and induces axonal regrowth of injured spinal cord. Neuropathology 30:3 (2010), 205–217.
17. Gyulveszi, G., Haak, S., Becher, B., IL-23-driven encephalo-tropism and Th17 polarization during CNS-inflammation in vivo. Eur. J. Immunol. 39:7 (2009), 1864–1869.
18. Heiseke, A.F., Faul, A.C., Lehr, H.A., Forster, I., Schmid, R.M., Krug, A.B., Reindl, W., CCL17 promotes intestinal inflammation in mice and counteracts regulatory T cell-mediated protection from colitis. Gastroenterology 142:2 (2012), 335–345.
19. Hori, S., Haury, M., Coutinho, A., Demengeot, J., Specificity requirements for selection and effector functions of CD25+4+ regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 99:12 (2002), 8213–8218.
20. Josefowicz, S.Z., Lu, L.F., Rudensky, A.Y., Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 30 (2012), 531–564.
21. Kohm, A.P., Carpentier, P.A., Anger, H.A., Miller, S.D., Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. (Baltimore, Md.: 1950) 169:9 (2002), 4712–4716.
22. Langrish, C.L., Chen, Y., Blumenschein, W.M., Mattson, J., Basham, B., Sedgwick, J.D., McClanahan, T., Kastelein, R.A., Cua, D.J., IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201:2 (2005), 233–240.
23. Lassmann, H., Models of multiple sclerosis: new insights into pathophysiology and repair. Curr. Opin. Neurol. 21:3 (2008), 242–247.
24. Lowther, D.E., Chong, D.L., Ascough, S., Ettorre, A., Ingram, R.J., Boyton, R.J., Altmann, D.M., Th1 not Th17 cells drive spontaneous MS-like disease despite a functional regulatory T cell response. Acta Neuropathol. 126:4 (2013), 501–515.
25. McGeachy, M.J., Stephens, L.A., Anderton, S.M., Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system. J.Immunol. (Baltimore, Md.: 1950) 175:5 (2005), 3025–3032.
26. McMahon, E.J., Bailey, S.L., Miller, S.D., CNS dendritic cells: critical participants in CNS inflammation?. Neurochem. Int. 49:2 (2006), 195–203.
27. Mekala, D.J., Alli, R.S., Geiger, T.L., IL-10-dependent infectious tolerance after the treatment of experimental allergic encephalomyelitis with redirected CD4+CD25+ T lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 102:33 (2005), 11817–11822.
28. Miller, S.D., McMahon, E.J., Schreiner, B., Bailey, S.L., Antigen presentation in the CNS by myeloid dendritic cells drives progression of relapsing experimental autoimmune encephalomyelitis. Ann. N. Y. Acad. Sci. 1103 (2007), 179–191.
29. Molinaro, R., Pecli, C., Guilherme, R.F., Alves-Filho, J.C., Cunha, F.Q., Canetti, C., Kunkel, S.L., Bozza, M.T., Benjamim, C.F., CCR4 controls the suppressive effects of regulatory T cells on early and late events during severe sepsis. PLoS One, 10(7), 2015, e0133227.
30. Montero, E., Nussbaum, G., Kaye, J.F., Perez, R., Lage, A., Ben-Nun, A., Cohen, I.R., Regulation of experimental autoimmune encephalomyelitis by CD4+, CD25+ and CD8+ T cells: analysis using depleting antibodies. J. Autoimmun. 23:1 (2004), 1–7.
31. Narikawa, K., Misu, T., Fujihara, K., Nakashima, I., Sato, S., Itoyama, Y., CSF chemokine levels in relapsing neuromyelitis optica and multiple sclerosis. J. Neuroimmunol. 149:1–2 (2004), 182–186.
32. Pashenkov, M., Huang, Y.M., Kostulas, V., Haglund, M., Soderstrom, M., Link, H., Two subsets of dendritic cells are present in human cerebrospinal fluid. Brain 124:Pt 3 (2001), 480–492.
33. Poppensieker, K., Otte, D.M., Schurmann, B., Limmer, A., Dresing, P., Drews, E., Schumak, B., Klotz, L., Raasch, J., Mildner, A., Waisman, A., Scheu, S., Knolle, P., Forster, I., Prinz, M., Maier, W., Zimmer, A., Alferink, J., CC chemokine receptor 4 is required for experimental autoimmune encephalomyelitis by regulating GM-CSF and IL-23 production in dendritic cells. Proc. Natl. Acad. Sci. U.S.A. 109:10 (2012), 3897–3902.
34. Reddy, J., Waldner, H., Zhang, X., Illes, Z., Wucherpfennig, K.W., Sobel, R.A., Kuchroo, V.K., Cutting edge: CD4+CD25+ regulatory T cells contribute to gender differences in susceptibility to experimental autoimmune encephalomyelitis. J. Immunol. (Baltimore, Md.: 1950) 175:9 (2005), 5591–5595.
35. Romagnani, S., Cytokines and chemoattractants in allergic inflammation. Mol. Immunol. 38:12–13 (2002), 881–885.
36. Ruck, T., Bittner, S., Epping, L., Herrmann, A.M., Meuth, S.G., Isolation of primary murine brain microvascular endothelial cells. J. Vis. Exp. JoVE, 93, 2014, e52204 doi, no. 93.
37. Segal, B.M., Experimental autoimmune encephalomyelitis: cytokines, effector T cells, and antigen-presenting cells in a prototypical Th1-mediated autoimmune disease. Curr. Allergy Asthma Rep. 3:1 (2003), 86–93.
38. Serafini, B., Rosicarelli, B., Magliozzi, R., Stigliano, E., Capello, E., Mancardi, G.L., Aloisi, F., Dendritic cells in multiple sclerosis lesions: maturation stage, myelin uptake, and interaction with proliferating T cells. J. Neuropathol. Exp. Neurol. 65:2 (2006), 124–141.
39. Stephens, L.A., Malpass, K.H., Anderton, S.M., Curing CNS autoimmune disease with myelin-reactive Foxp3+ Treg. Eur. J. Immunol. 39:4 (2009), 1108–1117.
40. Stutte, S., Quast, T., Gerbitzki, N., Savinko, T., Novak, N., Reifenberger, J., Homey, B., Kolanus, W., Alenius, H., Forster, I., Requirement of CCL17 for CCR7- and CXCR4-dependent migration of cutaneous dendritic cells. Proc. Natl. Acad. Sci. U.S.A. 107:19 (2010), 8736–8741.
41. Weber, C., Meiler, S., Doring, Y., Koch, M., Drechsler, M., Megens, R.T., Rowinska, Z., Bidzhekov, K., Fecher, C., Ribechini, E., van Zandvoort, M.A., Binder, C.J., Jelinek, I., Hristov, M., Boon, L., Jung, S., Korn, T., Lutz, M.B., Forster, I., Zenke, M., Hieronymus, T., Junt, T., Zernecke, A., CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice. J. Clin. Invest. 121:7 (2011), 2898–2910.
42. Weidenfeller, C., Schrot, S., Zozulya, A., Galla, H.J., Murine brain capillary endothelial cells exhibit improved barrier properties under the influence of hydrocortisone. Brain Res. 1053:1–2 (2005), 162–174.
43. Yogev, N., Frommer, F., Lukas, D., Kautz-Neu, K., Karram, K., Ielo, D., von Stebut, E., Probst, H.C., van den Broek, M., Riethmacher, D., Birnberg, T., Blank, T., Reizis, B., Korn, T., Wiendl, H., Jung, S., Prinz, M., Kurschus, F.C., Waisman, A., Dendritic cells ameliorate autoimmunity in the CNS by controlling the homeostasis of PD-1 receptor(+) regulatory T cells. Immunity 37:2 (2012), 264–275.
44. Yuan, Q., Bromley, S.K., Means, T.K., Jones, K.J., Hayashi, F., Bhan, A.K., Luster, A.D., CCR4-dependent regulatory T cell function in inflammatory bowel disease. J. Exp. Med. 204:6 (2007), 1327–1334.
45. Zozulya, A.L., Ortler, S., Lee, J., Weidenfeller, C., Sandor, M., Wiendl, H., Fabry, Z., Intracerebral dendritic cells critically modulate encephalitogenic versus regulatory immune responses in the CNS. J. Neurosci. 29:1 (2009), 140–152.
46. Zozulya, A.L., Wiendl, H., The role of regulatory T cells in multiple sclerosis. Nat. Clin. Pract. Neurol. 4:7 (2008), 384–398.